Introducing OR:BIT from HRW13.12.2017
Our team of Oncology Business Intelligence executives
For years clients have been coming to HRW with their business challenges in the Oncology space. This is nothing new…… but as the scientific understanding of tumours and gene mutations has grown, so has the personalisation and complexity of treatments.
As such, clients increasingly require a strategic research partner who not only keeps abreast of the changes in the marketplace, but also has a deep understanding of the science, the market dynamics, the stakeholders involved, as well as the recruitment strategies to deliver meaningful and actionable insight.
We have a long history of working in this complex field but have now formally established an internal team of experts, known as OR:BIT (Oncology Research: Business Intelligence Team), who consult exclusively on Oncology research projects and take results that one step further to ensure we exceed our clients’ expectations.
Our OR:BIT is truly global, with researchers based in the US and throughout the EU, and have a wealth of oncology-specific agency and pharma experience spanning over more than 20 years between them, with our senior team members having spent the last 7 years specialising exclusively in Oncology market research.
If you would like to find out more about OR:BIT and how we can support you throughout the project life cycle, from research design to analysis and beyond, or if you are interested in how we could become a strategic partner, please get in touch with Jo McDonald at email@example.com or HRW-ORBIT@hrwhealthcare.com.